6-sulfatoxymelatonin has been researched along with Cancer of Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, B; Hu, S; Shen, G; Xu, W; Yin, S | 1 |
| Bartsch, C; Bartsch, H; Franz, H; Kvetnaia, T; Kvetnoy, I; Mecke, D; Molotkov, A; Raikhlin, N | 1 |
| Fumagalli, L; Giani, L; Lissoni, P; Mandalà, M; Rovelli, F | 1 |
3 other study(ies) available for 6-sulfatoxymelatonin and Cancer of Lung
| Article | Year |
|---|---|
Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Circadian Rhythm; Female; Humans; Lung Neoplasms; Male; Melatonin; Middle Aged; Tryptophan | 2009 |
Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Gastrointestinal Neoplasms; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Melatonin; Middle Aged; Pineal Gland; Proliferating Cell Nuclear Antigen; Radioimmunoassay | 1997 |
Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients.
Topics: Adjuvants, Immunologic; Carcinoma, Renal Cell; Humans; Immunity, Innate; Immunotherapy; Inflammation Mediators; Interleukin-12; Interleukin-2; Interleukin-6; Kidney Neoplasms; Lung Neoplasms; Melatonin; Neopterin; Neurosecretory Systems; Pineal Gland; Receptors, Interleukin-2; Tumor Necrosis Factor-alpha | 1998 |